Organization
Cortendo
2 clinical trials
Clinical trial
A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open Label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's SyndromeStatus: Completed, Estimated PCD: 2020-06-30
Clinical trial
An Open-label Extension Study of Levoketoconazole (2S,4R-ketoconazole) in the Treatment of Endogenous Cushing's SyndromeStatus: Completed, Estimated PCD: 2022-12-31